you are here: HomeNewsOpinion

A $765-million shot across Indian pharma’s bows

India wants its pharmaceutical supply chain to become more self-sufficient but the US has a similar goal. What this could mean for Indian pharma.

July 29, 2020 / 01:29 PM IST
A $765-million shot across Indian pharma’s bows

If medicines are the main weapon in the fight against the COVID-19 pandemic, does securing access to drugs become a matter of national security? Governments seem to think so and are now taking actions so that they are not caught napping next time. That’s why the US is giving $765 million or Rs 5740 crore as a loan to Kodak under the Defense Production Act, to create capacity for making raw materials that are used to make generic drugs....

  • PRO Panorama

    Moneycontrol Pro Panorama | Citius, Altius, Fortius, Zomato 

    Jul 23, 2021 / 03:26 PM IST

    In today’s edition of Moneycontrol Pro Panorama: Zomato delivers, the weekly tactical, the allure of HUL, Bajaj Auto revs up, Herd Immunity Tracker, the Green Pivot, all eyes on COP26, and more

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers